Wicks, Ian P.
Roberts, Andrew W.
Article History
First Online: 3 December 2015
Competing interests
: I.P.W. declares that he collaborated with CSL Pty Ltd in the development of an anti-GM-CSF receptor antagonist program, which subsequently included a collaboration with MedImmune Pty Ltd. His lab has received funding from CSL and MedImmune for this program and for work on other colony-stimulating-factor (CSF) antagonists. A.W.R. has conducted two first-in-human clinical trials funded by CSL Pty Ltd.